Cambiano V - Search Results

1

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.

Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio S. Phillips AN, et al. Among authors: cambiano v. Lancet HIV. 2020 Mar;7(3):e193-e200. doi: 10.1016/S2352-3018(19)30400-X. Epub 2020 Feb 5. Lancet HIV. 2020. PMID: 32035041 Free PMC article.

2

Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.

Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Holloway J, Johnson M, Phillips AN. Cambiano V, et al. HIV Med. 2010 Mar;11(3):216-24. doi: 10.1111/j.1468-1293.2009.00771.x. Epub 2009 Dec 3. HIV Med. 2010. PMID: 20002781 Free article.

3

Long-term trends in adherence to antiretroviral therapy from start of HAART.

Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Puradiredja DI, Johnson M, Swaden L, Phillips AN. Cambiano V, et al. AIDS. 2010 May 15;24(8):1153-62. doi: 10.1097/QAD.0b013e32833847af. AIDS. 2010. PMID: 20299959

4

Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion.

Phillips AN, Lampe FC, Smith CJ, Geretti AM, Rodger A, Lodwick RK, Cambiano V, Tsintas R, Johnson MA. Phillips AN, et al. Among authors: cambiano v. AIDS. 2010 Jun 19;24(10):1561-7. doi: 10.1097/QAD.0b013e32833a6056. AIDS. 2010. PMID: 20505495

5

'Test-and-treat': the end of the HIV epidemic?

Cambiano V, Rodger AJ, Phillips AN. Cambiano V, et al. Curr Opin Infect Dis. 2011 Feb;24(1):19-26. doi: 10.1097/QCO.0b013e3283422c8c. Curr Opin Infect Dis. 2011. PMID: 21157329 Review.

6

Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings.

Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, Cambiano V, Lundgren J. Phillips AN, et al. Among authors: cambiano v. AIDS. 2011 Mar 27;25(6):843-50. doi: 10.1097/QAD.0b013e328344037a. AIDS. 2011. PMID: 21192233

7

Modelling the impact of treatment with individual antiretrovirals.

Cambiano V, Phillips AN. Cambiano V, et al. Curr Opin HIV AIDS. 2011 Mar;6(2):124-30. doi: 10.1097/COH.0b013e328343ad66. Curr Opin HIV AIDS. 2011. PMID: 21505387 Review.

8

Projected life expectancy of people with HIV according to timing of diagnosis.

Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, Delpech V, Phillips AN. Nakagawa F, et al. Among authors: cambiano v. AIDS. 2012 Jan 28;26(3):335-43. doi: 10.1097/QAD.0b013e32834dcec9. AIDS. 2012. PMID: 22089374

9

Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy.

Doyle T, Smith C, Vitiello P, Cambiano V, Johnson M, Owen A, Phillips AN, Geretti AM. Doyle T, et al. Among authors: cambiano v. Clin Infect Dis. 2012 Mar 1;54(5):724-32. doi: 10.1093/cid/cir936. Epub 2012 Jan 11. Clin Infect Dis. 2012. PMID: 22238167

10

The role of individual-based models in understanding the potential impact of antiretroviral therapy for prevention.

Cambiano V, Phillips AN. Cambiano V, et al. AIDS. 2012 Jul 17;26(11):1441-2. doi: 10.1097/QAD.0b013e3283546623. AIDS. 2012. PMID: 22767344 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters